The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs that has revolutionized obesity treatment
Laboratory research record on Cagrilintide [PMID: 41259769] PubMed laboratory record discussing Cagrilintide in a research context
If fatigue coincides with these changes, it is likely drug-related
Feature selection was performed using the minimum redundancy maximum relevance algorithm 68 and the logistic regression procedure, and fivefold cross-validation was used to derive optimal tuning parameters
Many patients do not give up on their obesity treatment journey, even if they need to stop their initial medication, said Dr
It should be taken at any time that is convenient, with or without food